Clinical trial

Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease

NCT00929734

Study summary

ClinicalTrials.gov

Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Rosuvastatin Normalized identity: rosuvastatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-03-01

PhasePHASE2

Conditions

Chronic Obstructive Pulmonary Disease (COPD)verified · MONDO: chronic obstructive pulmonary disease

Interventions

RosuvastatinDRUG · verified · RxNorm: rosuvastatin

PlaceboDRUG

Sponsors & collaborators

University Hospital, Akershuslead sponsor

AstraZenecacollaborator

Haukeland University Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00929734 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.